OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Designing a therapeutic hepatitis B vaccine to circumvent immune tolerance
David C. Whitacre, CJ Peters, Camille Sureau, et al.
Human Vaccines & Immunotherapeutics (2019) Vol. 16, Iss. 2, pp. 251-268
Open Access | Times Cited: 17

Showing 17 citing articles:

Self-assembled peptide and protein nanostructures for anti-cancer therapy: Targeted delivery, stimuli-responsive devices and immunotherapy
Masoud Delfi, Rossella Sartorius, Milad Ashrafizadeh, et al.
Nano Today (2021) Vol. 38, pp. 101119-101119
Open Access | Times Cited: 195

Hepatitis B vaccine development and implementation
Hong Zhao, Xiaoying Zhou, Yi‐Hua Zhou
Human Vaccines & Immunotherapeutics (2020) Vol. 16, Iss. 7, pp. 1533-1544
Open Access | Times Cited: 91

Protein Engineering: A Novel Approach in Vaccine Development
Diwas Adhikari, Sharada Pokhrel
Journal of Drug Delivery and Therapeutics (2025) Vol. 15, Iss. 2, pp. 137-142
Open Access

Critical Updates on Chronic Hepatitis B Virus Infection in 2021
Cyriac Abby Philips, Rizwan Ahamed, Jinsha K Abduljaleel, et al.
Cureus (2021)
Open Access | Times Cited: 20

Advances in Nanoparticle Drug Delivery Systems for Anti-Hepatitis B Virus Therapy: A Narrative Review
Jing Miao, Peng Gao, Qian Li, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11227-11227
Open Access | Times Cited: 13

PreS1 Containing HBc VLPs for the Development of a Combined Therapeutic/Prophylactic Hepatitis B Vaccine
Andris Dishlers, Ivars Petrovskis, Dace Skrastiņa, et al.
Microorganisms (2023) Vol. 11, Iss. 4, pp. 972-972
Open Access | Times Cited: 5

Hepatitis B eradication: vaccine as a key player.
Flor H. Pujol, Rayana Maryse Toyé, Carmen L. Loureiro, et al.
PubMed (2023) Vol. 15, Iss. 8, pp. 4971-4983
Closed Access | Times Cited: 5

A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection
Rani Burm, Freya Van Houtte, Lieven Verhoye, et al.
JHEP Reports (2022) Vol. 5, Iss. 3, pp. 100646-100646
Open Access | Times Cited: 8

Hepatitis B virus pre‐S region: Clinical implications and applications
Huizhen Sun, Le Chang, Ying Yan, et al.
Reviews in Medical Virology (2020) Vol. 31, Iss. 4
Closed Access | Times Cited: 12

Dynamics of Hepatitis B Virus Covalently Closed Circular DNA: A Mini-Review
Jieli Hu, Ailong Huang
Microorganisms (2023) Vol. 11, Iss. 3, pp. 600-600
Open Access | Times Cited: 3

Construction, expression and assemble of EMCV VLPs and their potency evaluation
Haixia Zhang, Shengjun Li, Jinxian Su, et al.
Virology (2023) Vol. 584, pp. 1-8
Open Access | Times Cited: 2

Hepatitis-B-Impfstoffe – Geschichte, Erfolge, Herausforderungen und Perspektiven
Wolfram H. Gerlich
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz (2022) Vol. 65, Iss. 2, pp. 170-182
Open Access | Times Cited: 4

Restricted TcR β chain CDR3 clonotype is associated with resolved acute hepatitis B subjects
Dangsheng Xiao, Wang Ju, Zhitao Chen, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 2

GENETIC TRANSFORMATION OF CARROT (DAUCAS CAROTA L.) TO EXPRESS HEPATITIS B SURFACE ANTIGEN GENE FOR EDIBLE VACCINE OF HBV
Satriyas Ilyas, Neha Asghar, Nur Faidah Munir, et al.
The Journal of Animal and Plant Sciences (2020) Vol. 30, Iss. 5
Open Access

Page 1

Scroll to top